Integral Diagnostics Limited
ITGDF
$1.00
-$1.06-51.41%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 404.42M | 363.09M | 324.08M | 317.04M | 308.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 404.42M | 363.09M | 324.08M | 317.04M | 308.04M |
| Cost of Revenue | 278.09M | 248.99M | 221.50M | 215.64M | 208.42M |
| Gross Profit | 126.34M | 114.09M | 102.58M | 101.40M | 99.62M |
| SG&A Expenses | 22.28M | 20.20M | 18.25M | 17.95M | 17.54M |
| Depreciation & Amortization | 36.47M | 33.81M | 31.36M | 31.14M | 30.73M |
| Other Operating Expenses | 17.15M | 15.30M | 13.55M | 13.60M | 13.57M |
| Total Operating Expenses | 367.15M | 330.33M | 295.60M | 288.89M | 280.38M |
| Operating Income | 37.28M | 32.76M | 28.47M | 28.15M | 27.66M |
| Income Before Tax | 7.40M | 6.63M | 5.94M | -15.62M | -37.28M |
| Income Tax Expenses | 4.35M | 3.26M | 2.21M | 2.28M | 2.34M |
| Earnings from Continuing Operations | 3.04 | 3.37 | 3.73 | -17.90 | -39.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -92.60K | -45.80K | -- | -- | -- |
| Net Income | 2.95M | 3.32M | 3.73M | -17.90M | -39.62M |
| EBIT | 37.28M | 32.76M | 28.47M | 28.15M | 27.66M |
| EBITDA | 55.46M | 49.86M | 44.57M | 44.13M | 43.42M |
| EPS Basic | 0.01 | 0.01 | 0.02 | -0.08 | -0.17 |
| Normalized Basic EPS | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
| EPS Diluted | 0.01 | 0.01 | 0.02 | -0.08 | -0.17 |
| Normalized Diluted EPS | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
| Average Basic Shares Outstanding | 1.23B | 1.09B | 962.49M | 948.24M | 933.99M |
| Average Diluted Shares Outstanding | 1.24B | 1.10B | 962.49M | 948.24M | 933.99M |
| Dividend Per Share | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Payout Ratio | 338.91% | 269.92% | 214.43% | -44.63% | -20.01% |